Description
GLOW is a defined three-component research blend combining BPC-157, GHK-Cu, and TB-500 in a single lyophilized vial. Each component operates through a mechanistically distinct pathway that does not directly overlap with the others, providing three independent research inputs into the same shared biological territory of vascular and extracellular matrix signaling. The blend is studied in recovery peptide tissue biology models where all three mechanistic axes are simultaneously active experimental variables. No peer-reviewed published study has tested this specific three-compound combination; the combination rationale is mechanistic rather than experimentally validated, and researchers using this blend should include single-compound control arms to attribute observed effects to individual components.
Chemical Information
BPC-157 Component:
- Chemical Name: BPC-157 (Body Protection Compound 157)
- Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- Molecular Formula: C62H98N16O22
- Molecular Weight: 1,419.5 g/mol
GHK-Cu Component:
- Chemical Name: GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex; Copper Tripeptide-1)
- Sequence: Gly-His-Lys
- Molecular Formula: C14H24N6O4Cu
- Molecular Weight: 401.9 g/mol
- Appearance: Blue powder (characteristic of copper coordination)
TB-500 Component:
- Chemical Name: TB-500 (Thymosin Beta-4 fragment; Ac-LKKTETQ)
- Sequence: Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln
- Molecular Weight: approximately 882 Da
Blend:
- Ratio Option 1: BPC-157 5mg / GHK-Cu 50mg / TB-500 2mg
- Ratio Option 2: BPC-157 10mg / GHK-Cu 50mg / TB-500 10mg
- Production: Solid-phase peptide synthesis (SPPS) for peptide components; copper coordination post-synthesis for GHK-Cu
Applications
- Multi-pathway tissue biology research. The three components address independent mechanistic axes (receptor/NO axis via BPC-157, transcriptional axis via GHK-Cu, cytoskeletal axis via TB-500) within overlapping vascular and ECM research territory; the blend enables simultaneous study of all three inputs in one experimental model
- Angiogenesis mechanism research. BPC-157 upregulates VEGFR2 without affecting VEGF-A levels; GHK-Cu increases VEGF and bFGF transcription; TB-500 supports endothelial cell migration through actin dynamics; the three angiogenic mechanisms are mechanistically independent and can be studied together or separated through single-compound control arms
- Extracellular matrix remodeling research. GHK-Cu drives collagen type I and III synthesis, elastin upregulation, and TIMP-1/TIMP-2 induction to regulate MMP activity; BPC-157 activates Egr-1 transcription factor driving PDGF and TGF-beta downstream; studying ECM dynamics with both present enables modeling of gene-level and growth-factor-level ECM regulation simultaneously
- Cell migration studies. TB-500’s G-actin sequestration mechanism enables actin polymerization at the leading edge of migrating cells; BPC-157 contributes through FAK/paxillin focal adhesion remodeling; the two compounds address cytoskeletal and adhesion aspects of cell migration through distinct mechanisms
- Combination versus single-compound comparative designs. The primary research value of the blend format is enabling experiments that directly compare three-compound combination effects against individual compound controls; researchers using this blend for combination biology require single-compound arms (BPC-157 alone, GHK-Cu alone, TB-500 alone) alongside the blend condition
Storage and Handling
Store lyophilized blend at -20C for long-term stability, or at 2-8C for short-term use. Protect from light, particularly important for the GHK-Cu component whose copper coordination is light-sensitive. The characteristic blue color of the lyophilized powder reflects GHK-Cu copper coordination and is not an indicator of contamination. Reconstitute in bacteriostatic water immediately before use; plain sterile water is acceptable for single-use experiments only. Avoid repeated freeze-thaw cycles. GHK-Cu is the most handling-sensitive component; reconstitution protocol should be optimized for the most fragile component in the blend.
Compliance Notice
GLOW is for laboratory research use only. It is not for human or veterinary use and carries no therapeutic, diagnostic, or clinical indication. This product has not been evaluated by the FDA. By purchasing this product, the buyer confirms that they will follow appropriate institutional safety procedures and use it exclusively for controlled research.
